Half-year report · HY
4937.TEDINET S100Y3R1
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥138m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥163m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥136m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥92m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.63 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.32 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.24 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 65.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-10-01 → 2026-03-31 | ¥95m |
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥208m |
| Direct To Consumer Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥163m |
| Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥88m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥251m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥346m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital stock | Prior1YearInstant | 54567000 | JPY |
| Capital stock | InterimInstant | 59667000 | JPY |
| Capital surplus | Prior1YearInstant | 2466417000 | JPY |
| Capital surplus | InterimInstant | 2471517000 | JPY |
| Retained earnings | Prior1YearInstant | -338607000 | JPY |
| Retained earnings | InterimInstant | -202121000 | JPY |
| Treasury stock | Prior1YearInstant | -99977000 | JPY |
| Treasury stock | InterimInstant | -99977000 | JPY |
| Shareholders equity | Prior1YearInstant | 2082400000 | JPY |
| Shareholders equity | InterimInstant | 2229085000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 9249000 | JPY |
| Subscription rights to shares | InterimInstant | 14413000 | JPY |
| Net assets | Prior1YearInstant | 2091650000 | JPY |
| Net assets | InterimInstant | 2243499000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 3199164000 | JPY |
| Liabilities and net assets | InterimInstant | 3397952000 | JPY |
| Net sales | Prior1InterimDuration | 834854000 | JPY |
| Net sales | InterimDuration | 1133473000 | JPY |
| Cost of sales | Prior1InterimDuration | 177474000 | JPY |
| Cost of sales | InterimDuration | 299757000 | JPY |
| Gross profit | Prior1InterimDuration | 657380000 | JPY |
| Gross profit | InterimDuration | 833715000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 709685000 | JPY |
| Selling general and administrative expenses | InterimDuration | 695544000 | JPY |
| Operating income | Prior1InterimDuration | -52305000 | JPY |
| Operating income | InterimDuration | 138170000 | JPY |
| Interest income noi | Prior1InterimDuration | 460000 | JPY |
| Interest income noi | InterimDuration | 835000 | JPY |
| Gain on bad debts recovered noi | Prior1InterimDuration | 1200000 | JPY |
| Gain on bad debts recovered noi | InterimDuration | － | JPY |
| Miscellaneous income noi | Prior1InterimDuration | 265000 | JPY |
| Miscellaneous income noi | InterimDuration | 80000 | JPY |
| Non operating income | Prior1InterimDuration | 1925000 | JPY |
| Non operating income | InterimDuration | 915000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 3949000 | JPY |
| Interest expenses noe | InterimDuration | 4551000 | JPY |
| Miscellaneous loss noe | Prior1InterimDuration | 239000 | JPY |
| Miscellaneous loss noe | InterimDuration | － | JPY |
| Non operating expenses | Prior1InterimDuration | 4188000 | JPY |
| Non operating expenses | InterimDuration | 4551000 | JPY |
| Ordinary income | Prior1InterimDuration | -54568000 | JPY |
| Ordinary income | InterimDuration | 134535000 | JPY |
| Income before income taxes | Prior1InterimDuration | -54568000 | JPY |
| Income before income taxes | InterimDuration | 134535000 | JPY |
| Income taxes current | Prior1InterimDuration | 4595000 | JPY |
| Income taxes current | InterimDuration | 1452000 | JPY |
| Income taxes deferred | Prior1InterimDuration | － | JPY |
| Income taxes deferred | InterimDuration | -3403000 | JPY |
| Income taxes | Prior1InterimDuration | 4595000 | JPY |
| Income taxes | InterimDuration | -1950000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |